ATRA

Health Care Sector Update for 09/05/2017: ATRA

A generic image of a pen on a chart Credit: Shutterstock photo

Top Health-care stocks:

JNJ: flat

PFE: -0.3%

ABT: flat

MRK: flat

AMGN: flat

Health-care shares were mainly unchanged in pre-market trade Tuesday.

In health-care stocks news, Atara Biotherapeutics ( ATRA ) said Tuesday that its ATA230 has been granted orphan drug designation for the treatment of cytomegalovirus (CMV) viremia and disease in immunocompromised patients by the U.S. Food and Drug Administration.

Shares in the company were unchanged at $15.25 in early trade. The stock has traded between $11.80 and $23 over the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.